Literature DB >> 25275773

Central nervous system involvement in relapsing polychondritis.

Kalpita Hatti1, Vincent Giuliano.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25275773     DOI: 10.1097/RHU.0000000000000155

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  6 in total

Review 1.  Aseptic meningitis in relapsing polychondritis: a case report and literature review.

Authors:  Kai Shen; Geng Yin; Chenlu Yang; Qibing Xie
Journal:  Clin Rheumatol       Date:  2017-03-30       Impact factor: 2.980

2.  Relapsing Polychondritis with Meningoencephalitis Refractory to Immunosuppressant Therapy.

Authors:  Mohammad Mousbah Al-Tabbaa; Hani Habal
Journal:  Case Rep Neurol Med       Date:  2018-10-03

3.  Limbic encephalitis with relapsing polychondritis: persistent white matter lesions and brain atrophy.

Authors:  Zilong Zhu; Decai Tian; Ning Ren; Zhihong Zhao; Xin Wang; Lei Chen
Journal:  J Int Med Res       Date:  2018-11-14       Impact factor: 1.671

4.  Elucidation of predictors of disease progression in patients with relapsing polychondritis at the onset: potential impact on patient monitoring.

Authors:  Jun Shimizu; Yoshihisa Yamano; Kimito Kawahata; Noboru Suzuki
Journal:  BMC Rheumatol       Date:  2020-09-11

5.  Comparison of relapsing polychondritis patients with and without central nervous system involvement: A retrospective study of 181 patients.

Authors:  Xiaoyu Cao; Lixiu Zhu; Huijuan Li; Li Jiang; Dong Xu; Jiuliang Zhao; Jiaxin Zhou; Fengchun Zhang; Yong Hou; Xiaofeng Zeng
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

6.  Meningoencephalitis in relapsing polychondritis: A case report.

Authors:  Haruki Matsumoto; Ryo Tokimura; Yuya Fujita; Naoki Matsuoka; Tomoyuki Asano; Shuzo Sato; Jumpei Temmoku; Makiko Yashiro-Furuya; Kenji Yoshida; Ryoma Takahashi; Shoko Tanaka; Yuya Itagaki; Mari Honma; Nozomu Matsuda; Hiroshi Watanabe; Kiyoshi Migita; Kazuaki Kanai
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.